Oncology PracticeDiet appears to play an important role in response to anti-PD-1 cancer immunotherapyMarch 1, 2019Immuno-oncologyMelanomaPatient & Survivor Care
Oncology PracticeBarriers to CAR T use in the spotlight at first European meetingFebruary 28, 2019Immuno-oncologyImmunotherapyB Cell LymphomaAggressive LymphomasCellular TherapyBusiness of MedicineGene Therapy
Oncology PracticeModel shows nivolumab plus ipilimumab cost effective in mRCCFebruary 25, 2019Practice ManagementGenitourinary CancerRenal Cell CarcinomaImmuno-oncologyBusiness of Medicine
Hematology NewsZUMA-1 update: Axi-cel responses persist at 2 yearsFebruary 24, 2019B Cell LymphomaCellular TherapyTransplantationLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsDual-targeted CAR T shows ‘clinical signal’ in NHLFebruary 24, 2019B Cell LymphomaMantle Cell LymphomaCellular TherapyTransplantationLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsAnti-GM-CSF antibody reduced CAR T-cell toxicityFebruary 24, 2019TransplantationCellular TherapyTranslational ResearchImmuno-oncology
Oncology PracticeFirst-line avelumab/axitinib for RCC benefits wide range of patientsFebruary 21, 2019Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Oncology PracticeFDA approves pembrolizumab for completely resected melanomaFebruary 19, 2019MelanomaImmuno-oncology
Hematology NewsCAR T-cell therapies difficult to compareFebruary 16, 2019B Cell LymphomaImmuno-oncologyLymphoma & Plasma Cell Disorders
Oncology PracticeCMS proposes coverage of CAR T-cell therapy in trialsFebruary 15, 2019Practice ManagementBusiness of MedicineTransplantationImmuno-oncologyImmunotherapyGene Therapy
Oncology PracticePembrolizumab extends Merkel cell PFS, OSFebruary 13, 2019Immuno-oncologyNonmelanoma Skin Cancer
Oncology PracticePembrolizumab-axitinib nearly halves risk of death in RCCFebruary 12, 2019Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Hematology NewsPD-1 blockade plus CD19 CAR T boosts CAR T-cell persistenceFebruary 8, 2019ALLPediatricsLeukemia, Myelodysplasia, TransplantationImmuno-oncologyCellular TherapyTransplantation
Oncology PracticeCheckpoint inhibitors ‘viable treatment option’ in HIV-infected individualsFebruary 8, 2019Immuno-oncologyLung CancerSarcoma & GISTMelanoma
Oncology PracticeEnoblituzumab plus pembrolizumab shows promise for select solid tumorsFebruary 7, 2019Lung CancerImmuno-oncologyHead & Neck/Thyroid Cancers
